Cargando…
BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19(high) B lymphocytes
BACKGROUND: The standard treatment for epithelial ovarian carcinoma (EOC) is surgery followed by platinum/paclitaxel-based chemotherapy, but the overall survival rate is poor. The purpose of this study was to investigate the therapeutic potential of chemotherapy combined with inhibition of B and T l...
Autores principales: | Chen, Yu-Li, Lin, Han-Wei, Chien, Chung-Liang, Lai, Yen-Ling, Sun, Wei-Zen, Chen, Chi-An, Cheng, Wen-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868712/ https://www.ncbi.nlm.nih.gov/pubmed/31753019 http://dx.doi.org/10.1186/s40425-019-0744-4 |
Ejemplares similares
-
Dual inhibition of BTLA and PD-1 can enhance therapeutic efficacy of paclitaxel on intraperitoneally disseminated tumors
por: Sun, Wei-Zen, et al.
Publicado: (2023) -
Study of the Expression of Inflammatory Factors IL-4, IL-6, IL-10, and IL-17 in Liver Failure Complicated by Coagulation Dysfunction and Sepsis
por: Li, Lei, et al.
Publicado: (2021) -
B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity
por: Piancone, Federica, et al.
Publicado: (2016) -
TNF-α blockade induces IL-10 expression in human CD4+ T cells
por: Evans, Hayley G., et al.
Publicado: (2014) -
TNF Blockade Maintains an IL-10(+) Phenotype in Human Effector CD4(+) and CD8(+) T Cells
por: Roberts, Ceri A., et al.
Publicado: (2017)